General Information of Drug (ID: DMBFX7S)

Drug Name
TgBSSL Drug Info
Indication
Disease Entry ICD 11 Status REF
Pancreatic malfunction DC30-DC3Z Investigative [1]
Cross-matching ID
TTD Drug ID
DMBFX7S

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bucelipase alfa DM50SNX Exocrine pancreatic insufficiency DC35.1 Phase 3 [2]
Taurocholic Acid DM2LZ8F Type-2 diabetes 5A11 Phase 1/2 [3]
CVT-1 DMPWZCI Hypercholesterolaemia 5C80.0 Terminated [4]
PMID24556381C10l DMOH45T Discovery agent N.A. Investigative [5]
PMID24556381C10f DMK6GAU Discovery agent N.A. Investigative [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bile-salt-activated lipase (CEL) TTTRNQW CEL_HUMAN Modulator [1]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2872).
2 ClinicalTrials.gov (NCT00743483) Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency. U.S. National Institutes of Health.
3 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
4 Lack of effect of cholesterol esterase inhibitor CVT-1 on cholesterol absorption and LDL cholesterol in humans. Cardiovasc Drugs Ther. 1999 Sep;13(5):449-54.
5 Synthesis and evaluation of 2-(1H-indol-3-yl)-4-phenylquinolines as inhibitors of cholesterol esterase. Bioorg Med Chem Lett. 2014 Mar 15;24(6):1545-9.